Ischemia-modified albumin use as a prognostic factor in coronary bypass surgery

BACKGROUND: Various types of markers have been used so far in order to reveal myocardial perfusion defect. However, these markers usually appear in the necrosis phase or in the late stage. Having been the focus of various investigations recently, ischemia-modified albumin (IMA) is helpful in establi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanko, Muhip, Yavuz, Sadan, Duman, Can, Hosten, Tulay, Oner, Emin, Berki, Turan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398305/
https://www.ncbi.nlm.nih.gov/pubmed/22221979
http://dx.doi.org/10.1186/1749-8090-7-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398305/
https://www.ncbi.nlm.nih.gov/pubmed/22221979
http://dx.doi.org/10.1186/1749-8090-7-3

Ejemplares similares